secwatch.observer — SEC 8-K summary
======================================

Issuer:     Camp4 Therapeutics Corp (CAMP)
CIK:        0001736730
Form:       8-K
Filed at:   2025-03-18T23:59:59+00:00
Accession:  0001736730-25-000004
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CAMP4 Therapeutics appoints two new directors, expands board to 12 members
--------------------------------------------------------------------------

- Douglas Williams, PhD and Murray Stewart, DM FRCP appointed as Class I and Class II directors, effective 3/17/25.
- Board size increased from 10 to 12 members; Williams also appointed to Audit Committee.
- Each new director granted option to purchase 17,787 shares under 2024 Equity Incentive Plan, vesting monthly over 3 years.
- Standard indemnification agreements entered into; no prior transactions with company exceeding $120,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736730/000173673025000004/0001736730-25-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736730/000173673025000004/camp-20250312.htm
  HTML page:      https://secwatch.observer/filing/0001736730-25-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer